Vera Therapeutics (VERA) Debt Ratio (2021 - 2026)

Vera Therapeutics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.12 for Q1 2026.

• Quarterly Debt Ratio rose 47.27% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (up 47.27% YoY) and the FY2025 annual result came in at 0.1, up 33.57% from the prior year.
• Debt Ratio was 0.12 for Q1 2026 at Vera Therapeutics, up from 0.1 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.28 in Q4 2023 and bottomed at 0.04 in Q1 2022.
• A 5-year average of 0.12 and a median of 0.13 in 2024 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio surged 316.8% — and 2024, when it plunged 73.16%.
• Vera Therapeutics' Debt Ratio stood at 0.21 in 2022, then surged by 34.43% to 0.28 in 2023, then plunged by 73.16% to 0.08 in 2024, then soared by 33.57% to 0.1 in 2025, then grew by 18.48% to 0.12 in 2026.
• Business Quant data shows VERA's Debt Ratio at 0.12 in Q1 2026, 0.1 in Q4 2025, and 0.14 in Q3 2025.